KDM4A and esophageal squamous cell carcinoma: Due to the deficiency of antibodies against Pep‐KDM4A‐AS1 peptide, TRAP assay, and ESCC MS dataset identification are very imperative to validate the translation potential of lncRNA KDM4A‐AS1 in ESCC.